Mass General at North Shore Cancer Center — Danvers, Massachusetts

Mass General at North Shore Cancer Center is a clinical research site located in Danvers, Massachusetts, United States 01923.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Mass General at North Shore Cancer Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Epithelial Ovarian Carcinoma, Pancreas Adenocarcinoma, Breast Cancer.

Sponsors: Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General at North Shore Cancer Center?

Mass General at North Shore Cancer Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General at North Shore Cancer Center conducted?

Mass General at North Shore Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Epithelial Ovarian Carcinoma, Pancreas Adenocarcinoma, Breast Cancer.

Is Mass General at North Shore Cancer Center accredited by Crixeo Health?

Mass General at North Shore Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General at North Shore Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.